In this review, we explored how the therapeutic inhibition of the immunosuppressive CD73/adenosine pathway and the resulting altered ATP/adenosine dynamics in the lung tissue could exacerbate the development of radiation pneumonitis in patients receiving thoracic chemo-radiotherapy combined with ICI-based immunotherapy. This evidence concerns the gene NT5E and radiation pneumonitis.